Tesei A - Search Results

1

Efficacy of different sequences of radio- and chemotherapy in experimental models of human melanoma.

Arienti C, Zoli W, Pignatta S, Carloni S, Paganelli G, Ulivi P, Romeo A, Menghi E, Sarnelli A, Medri L, Polico R, Silvestrini R, Tesei A. Arienti C, et al. Among authors: tesei a. J Cell Physiol. 2014 Oct;229(10):1548-56. doi: 10.1002/jcp.24598. J Cell Physiol. 2014. PMID: 24591063

2

Combined 4-hydroxy-ifosfamide and vinorelbine treatment in established and primary human breast cell cultures.

Ricotti L, Barzanti F, Tesei A, Amadori D, Gasperi-Campani A, Frassineti GL, Zoli W. Ricotti L, et al. Among authors: tesei a. Ann Oncol. 2000 May;11(5):587-94. doi: 10.1023/a:1008340902093. Ann Oncol. 2000. PMID: 10907953 Free article.

3

Lanreotide-induced modulation of 5-fluorouracil or mitomycin C cytotoxicity in human colon cancer cell lines: a preclinical study.

Tesei A, Ricotti L, De Paola F, Casini-Raggi C, Barzanti F, Frassineti GL, Zoli W. Tesei A, et al. J Chemother. 2000 Oct;12(5):421-30. doi: 10.1179/joc.2000.12.5.421. J Chemother. 2000. PMID: 11128563

4

In vitro preclinical models for a rational design of chemotherapy combinations in human tumors.

Zoli W, Ricotti L, Tesei A, Barzanti F, Amadori D. Zoli W, et al. Among authors: tesei a. Crit Rev Oncol Hematol. 2001 Jan;37(1):69-82. doi: 10.1016/s1040-8428(00)00110-4. Crit Rev Oncol Hematol. 2001. PMID: 11164721 Review.

5

In Vitro schedule-dependent interactions between the multitargeted antifolate LY231514 and gemcitabine in human colon adenocarcinoma cell lines.

Tesei A, Ricotti L, De Paola F, Amadori D, Frassineti GL, Zoli W. Tesei A, et al. Clin Cancer Res. 2002 Jan;8(1):233-9. Clin Cancer Res. 2002. PMID: 11801564

6

Flow-cytometric determination of tumor cells in lymph nodes.

Zoli W, Barzanti F, Dal Susino M, De Paola F, Tesei A, Ricotti L, Padovani F, Renò F, Amadori D. Zoli W, et al. Among authors: tesei a. Oncology. 2002;62(2):128-35. doi: 10.1159/000048258. Oncology. 2002. PMID: 11914598

7

In vitro schedule-dependent interaction between docetaxel and gemcitabine in human gastric cancer cell lines.

Ricotti L, Tesei A, De Paola F, Ulivi P, Frassineti GL, Milandri C, Amadori D, Zoli W. Ricotti L, et al. Among authors: tesei a. Clin Cancer Res. 2003 Feb;9(2):900-5. Clin Cancer Res. 2003. PMID: 12576465

8

NCX 4016, a nitric oxide-releasing aspirin derivative, exhibits a significant antiproliferative effect and alters cell cycle progression in human colon adenocarcinoma cell lines.

Tesei A, Ricotti L, Ulivi P, Medri L, Amadori D, Zoli W. Tesei A, et al. Int J Oncol. 2003 Jun;22(6):1297-302. Int J Oncol. 2003. PMID: 12738997

9

Potentiation of antiproliferative drug activity by lonidamine in hepatocellular carcinoma cells.

Ricotti L, Tesei A, De Paola F, Milandri C, Amadori D, Frassineti GL, Ulivi P, Zoli W. Ricotti L, et al. Among authors: tesei a. J Chemother. 2003 Oct;15(5):480-7. doi: 10.1179/joc.2003.15.5.480. J Chemother. 2003. PMID: 14598941

10

Schedule-dependent cytotoxic interaction between epidoxorubicin and gemcitabine in human bladder cancer cells in vitro.

Zoli W, Ricotti L, Tesei A, Ulivi P, Gasperi Campani A, Fabbri F, Gunelli R, Frassineti GL, Amadori D. Zoli W, et al. Among authors: tesei a. Clin Cancer Res. 2004 Feb 15;10(4):1500-7. doi: 10.1158/1078-0432.ccr-1107-03. Clin Cancer Res. 2004. PMID: 14977854

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

130 results

Search Page

Filters